COMPANY · NIPC 514194880

Kyowa Kirin Farmacêutica, Unipessoal, Lda.

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €17,731,345.72 across 209 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameKyowa Kirin Farmacêutica, Unipessoal, Lda.
NIPC514194880

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2018 to 2024. The table below gives the same values.2018: €14,447.6720182019: €115,059.5120192020: €1,277,136.2920202021: €1,751,277.7320212022: €4,294,462.4320222023: €5,410,032.5020232024: €4,868,929.592024€5,410,032.50
Contracted value by year
YearContractsContract value
20186€14,447.67
201926€115,059.51
202038€1,277,136.29
202157€1,751,277.73
202242€4,294,462.43
202319€5,410,032.50
202421€4,868,929.59
Contracted value by place of performance
NameContractsContract value
Lisboa46€6,769,325.18
Porto34€3,725,339.87
Coimbra14€3,567,221.17
Faro9€1,330,126.82
Guimarães6€756,914.88
Viseu4€278,806
Viana do Castelo8€212,570.63
Setúbal6€195,534.07
Braga4€84,538.10
Almada5€24,050.28
Largest contracts
SubjectYearContract value
040100222023-BUROSUMAB SOL INJ FR 1 ML SC2023€1,247,208
Aquisição dos medicamentos Burosumab 20mg/1ml Sol inj Fr SC + Burosumab 30mg/1ml Sol inj Fr SC2024€942,594
Medicamentos Exclusivos da Empresa Kyowa Kirin2023€936,570
Aquisição do medicamento BUROSUMAB 30MG/1ML SOL INJ FR SC e BUROSUMAB 20MG/1ML SOL INJ FR SC2022€795,858.70
BUROSUMAB 30 MG/1 ML SOL INJ FR 1 ML SC2024€694,169.28

Who they competed with

In 1,078 contracts with a list of competitors, the company took part and was awarded 103 (10%).

Companies with the most procedures in common
CompanyProcedures in common
generis79
overpharma75
labesfal, sa72
Myland, Lda.72
hikma lda69
farmoz63
b.braun53
Zentiva, Lda.43
dla sa42
Fresenius Kabi Pharma, Lda.42
sandoz42
accord41
grunenthal36
unilfarma33
Medinfar33
Mundipharma-Pharmacêutica, Lda.32
angelini31
korangi29
PLS Pharma, Produtos Farmacêuticos, Lda27
Jassen-Cilag Farmaceutica, Lda.24
Sidefarma, S.A.24
Teve Pharma21
sanofi20
pharmakern portugal20
Alloga, S.A.19
glaxo18
Tecnimede, SA17
Logista e Pharma, Lda.17
Normon, SA17
Lundeck16

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents37 companies and 60 links. The list below gives the same content as text.grunenthal (NIPC 500101965)grunenthalsanofi (NIPC 500134960)sanofiJassen-Cilag F… (NIPC 500189412)Jassen-Cilag F…unilfarma (NIPC 500293023)unilfarmaMedinfar (NIPC 500384045)Medinfarangelini (NIPC 500583650)angeliniTecnimede, SA (NIPC 500626413)Tecnimede, SASidefarma, S.A. (NIPC 500717419)Sidefarma, S.A.labesfal, sa (NIPC 501169580)labesfal, safarmoz (NIPC 501505334)farmozNIPC 514194880 (NIPC 514194880)NIPC 514194880+26 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.